Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Genome-wide gene expression in a pharmacological hormonal transition model and its relation to depressive symptoms

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. The association between depressive mood and ischemic heart disease: a twin study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Lithium as the drug of choice for maintenance treatment in bipolar disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Alcohol and delirium tremens: effects of average number of drinks per day and beverage type

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Parental alcohol use disorder with and without other mental disorders and offspring alcohol use disorder

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Optimization of preprocessing strategies in Positron Emission Tomography (PET) neuroimaging: A [11C]DASB PET study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The clinical use of Anti-Müllerian Hormone in female reproduction.

    Research output: Book/ReportPh.D. thesisResearch

  3. Three weeks of SSRI administration enhances the visual perceptual threshold - a randomized placebo-controlled study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

OBJECTIVES: Sensitivity to sex-steroid hormone fluctuations may increase risk for perinatal depression. We aimed to identify genome-wide biological profiles in women demonstrating sensitivity to pharmacological sex-hormone manipulation with gonadotrophin-releasing hormone agonist (GnRHa).

METHODS: Longitudinal gene expression (Illumina Human HT12.v4) and DNA methylation data (Infinium HumanMethylation450K BeadChip) from 60 women (30 GnRHa, 30 placebo) were generated (Trial ID: NCT02661789). Differences between baseline and two follow-up points (initial stimulation- and subsequent early suppression phase) in the biphasic ovarian hormone response to GnRHa were assessed using linear mixed effects models.

RESULTS: Genome-wide analysis revealed 588 probes differentially expressed from GnRHa intervention to first stimulatory phase follow-up (intervention group × time) after 10% fdr multiple testing correction. Of these, 54% genes were also significantly associated with estradiol changes over time (proxy for GnRHa response magnitude), 9.5% were associated with changes in depressive symptoms, and 38% were associated with changes in neocortical serotonin transporter binding. The genes were implicated in TGF beta signaling, adipogenesis, regulation of actin cytoskeleton, and focal adhesion pathways and enriched for DNA methylation changes (P = 0.006).

CONCLUSIONS: These findings point toward an altered peripheral blood transcriptomic landscape in a pharmacological model of sex-hormone-induced depressive symptoms.

Original languageEnglish
JournalActa Psychiatrica Scandinavica
Volume140
Issue number1
Pages (from-to)77-84
Number of pages8
ISSN0001-690X
DOIs
Publication statusPublished - Jul 2019

    Research areas

  • biomarkers, depressive symptoms, DNA methylation, estrogen, gene expression

ID: 57325156